Kapadia, S R <br/><br/>
Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy.  [electronic resource] 

 -  Stroke  Oct 2001 
 - 2328-32 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1524-4628 
<br/><br/><label>Standard No.: </label>10.1161/hs1001.096003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Adjuvants, Pharmaceutic--therapeutic use<br/>Aged<br/>Antibodies, Monoclonal--adverse effects<br/>Blood Vessel Prosthesis Implantation--adverse effects<br/>Carotid Artery Diseases--surgery<br/>Female<br/>Graft Occlusion, Vascular--etiology<br/>Humans<br/>Immunoglobulin Fab Fragments--adverse effects<br/>Intracranial Hemorrhages--etiology<br/>Male<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Risk Assessment<br/>Risk Factors<br/>Stents--adverse effects<br/>Thromboembolism--etiology<br/>Treatment Outcome<br/>Urokinase-Type Plasminogen Activator--therapeutic use